Christine Blank is a contributing editor.
Antibiotics Linked to Higher IBD Risk in Older Adults
Seniors prescribed multiple courses of antibiotics were at greater risk for IBD.
Despite Aggressive Recruiting, a Surplus of Pharmacy Jobs Remain Unfilled
Burnout, COVID-19 vaccines, and increased demands have come together to create the perfect storm of labor shortages within the industry.
Study: VKAs Better Protect Aortic Valve Replacement Patients
Study finds higher Ischemic events and mortality in transcatheter valve replacement patients taking non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists.
AF Patients Taking OACs Have Lower Dementia Risk
Low-risk atrial fibrillation patients who take oral anticoagulants have a lower risk of dementia than those who do not, a study says.
DOAC Use Increasing in Nursing Homes
The use of direct‐acting oral anticoagulants has increased among nursing home residents with atrial fibrillation.
Atrial Fibrillation Patients Often Overestimate Stroke and Bleeding Risks
Overestimating the bleeding risk of anticoagulants may lead to poor compliance.
Bleeding Improved with Apixaban versus VKA
Bleeding in patients with nonvalvular atrial fibrillation and coronary syndrome was reduced by apixaban versus vitamin K antagonists.
Kidney Disease Patients May Not Be Getting OACs
Many kidney disease patients with atrial fibrillation are not treated with anticoagulation, increasing their risk of stroke.
Patients with Cognitive Impairment Less Likely to Get OACs
Study finds different anticoagulation treatment levels for patients with cognitive problems.
Two Studies Show Efficacy of Rivaroxaban, Other NOACs in Preventing Stroke
A meta-analysis of 95 studies indicates lower risk of stroke and intracranial hemorrhage.
Racial Disparities Found in Oral Anticoagulant Prescription Patterns
Black patients with atrial fibrillation are less likely to be treated with oral anticoagulants or DOACs.
Choice of Anticoagulant and Cotherapy with a PPI Affect Gastrointestinal Bleeding Risk
The risk of gastrointestinal bleeding appears to be highest with rivaroxaban and lowest with apixaban, but is reduced by cotherapy with proton pump inhibitors.
What New Flu Drug Means for Other Treatments, Vaccine
The FDA has approved the first new treatment for flu in decades. Here's how it will impact sales of Tamiflu and vaccination rates.
New Xarelto Safety Warning Issued
ISMP reports that some patients have inadvertently taken double doses of rivaroxaban in dosing mixups.
Trump Signs Anti-Gag Clause Law
There is finally relief from “gag clauses,” which prevented pharmacists from telling patients they can pay a lower out-of-pocket cost for certain prescriptions than the copay with their health insurance.
Rivaroxaban Reduces Blood Clots After Medical Hospitalizations
A study found that treating patients with rivaroxaban for 45 days after hospital discharge reducedthe rate of nonfatal blood clots, but had no effect on fatal blood clots.
Apixaban Is Only NOAC with Lower Stroke Rate for Both Doses Compared to Warfarin in Large Study
A massive retrospective study compared several non-vitamin K antagonist oral anticoagulants (NOACs) to warfarin.
The Surgeon General Wants More Naloxone, Now What?
What do pharmacies have to do with the recent Surgeon General Advisory? A lot, actually.
Apixaban, Warfarin Equally Safe, Study Finds
A study found that apixaban is a safe alternative to VKAs for ablation of atrial fibrillation.
The 4 Ways Pharmacy Is Evolving
If the past few weeks are any indication, pharmacy isn’t going to be the same for very long.
New Bleeding Reversal Agent Shows Promise
Andaxanet alfa has shown effectiveness for patients needing hemostasis.
Small Doses: March 2018 Edition
Easy-to-swallow news and studies for the busy pharmacist.
MS Drug Removal Leaves Patients with Fewer Options
Zinbryta was taken off the market, leaving many patients with poor options.
Why Drug Stores Should Fear Amazon's OTC Move
Amazon quietly rolled out a line of OTC products-and that should scare you.
Pharmacy Settles Opioid Death Suit for $325,000
An independent pharmacy opted to settle a wrongful death lawsuit involving an opioid prescription.
Are More Blister Packs a Good Thing?
In an effort to combat opioids, the FDA is pushing blister packs-something pharmacy groups have been advocating for.
New Anticoagulant Guidelines for Cardiac Surgery Released
Three medical groups have issued guidelines for the use of anticoagulants during cardiac surgery.
A DOAC Provides Heparin Alternative to Cancer Patients
The DOAC edoxaban can replace dalteparin for treating cancer patients with venous thromboembolism.
2 Clarke Drive Cranbury, NJ 08512